|Articles|January 27, 2023

AJMC® in the Press, January 27, 2023

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A study published in the November 2022 issue of The American Journal of Managed Care^® was cited in articles by Earth.com and MedicalXpress. The study, “COVID-19 Surges and Hospital Outcomes in the United States,” found increased hospital mortality odds among non–COVID-19 patients, implying compromised quality of care during COVID-19 surges. Additionally, no large-scale changes were found in discharges to other facilities.

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Trending on AJMC

AJMC® in the Press, January 27, 2023

Related Content

Smartwatch Study Links Midlife to Rising Nighttime Awakenings in Women

FDA Approves Gwyn Lo, a New Low-Dose Contraceptive Patch

Global HepB3 Coverage Reaches 81.8%, but Regional Gaps Persist

Rituximab Matches Ocrelizumab in Head-to-Head MS Trial

Gaps Persist in Interstitial Lung Disease Care

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

Almost No Public Awareness of Lp(a), Elevated CVD Risk in the US: Katherine Wilemon

5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care

GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH

Rituximab Matches Ocrelizumab in Head-to-Head MS Trial

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

AJMC® in the Press, January 27, 2023

Related Content

Smartwatch Study Links Midlife to Rising Nighttime Awakenings in Women

FDA Approves Gwyn Lo, a New Low-Dose Contraceptive Patch

Global HepB3 Coverage Reaches 81.8%, but Regional Gaps Persist

Rituximab Matches Ocrelizumab in Head-to-Head MS Trial

Gaps Persist in Interstitial Lung Disease Care

Trending on AJMC

FDA Approves Moderna’s mRNA Flu Vaccine After Phase 3 Success

Almost No Public Awareness of Lp(a), Elevated CVD Risk in the US: Katherine Wilemon

5 Novel FDA Approvals That Signal a Shift Toward Convenience-Driven Care

GLP-1 Plus Glucagon: The Mechanistic Case for Dual Receptor Agonism in Obesity and MASH

Rituximab Matches Ocrelizumab in Head-to-Head MS Trial